Results 251 to 260 of about 468,048 (310)

Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures. [PDF]

Front Immunol
Fiore-Gartland A, Mayer-Blackwell K, Stray J, Neradilek M, Lo A, Hannah A, Dong T, Serebryannyy L, Carroll R, Lin BC, Koup RA, Garcia NMG, Marcelin JR, Pettifor AE, Janes H, Brown ER, Yen C, Andriesen J, Corey L, Stephenson KE, Kublin JG.   +20 more
europepmc   +1 more source

Experimental Investigation of Fentanyl Analgesic Potency and Its Relationship with Endogenous Adrenaline Levels in Rats. [PDF]

J Pain Res
Ates I, Isik B, Sezgin ET, Altuner D, Coban TA, Suleyman H.   +5 more
europepmc   +1 more source

Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines. [PDF]

Int J Pharm X
Arman BY, Magri A, Barbaglia MN, Petherbridge L, Brook J, Bharucha T, Legge I, Walsby-Tickle J, Deats M, Banerjee S, Mosca S, Jena R, Ranade DS, Chunekar SR, Patil KD, Gairola S, Merchant HA, Stokes R, Kuwana R, Maes A, James T, Green C, McCullagh J, Matousek P, Caillet C, Newton PN, Zitzmann N, Gangadharan B.   +27 more
europepmc   +1 more source

Reply to Peigneur et al. The Helix Ring Peptide U11 from the Venom of the Ant, Tetramorium bicarinatum, Acts as a Putative Pore-Forming Toxin, Not a New Kv1.3 Channel Blocker. Comment on "Boy et al. A New Kv1.3 Channel Blocker from the Venom of the Ant Tetramorium bicarinatum. Toxins 2025, 17, 379". [PDF]

Toxins (Basel)
Boy G, Jouvensal L, Téné N, Carayon JL, Bonnafé E, Paquet F, Treilhou M, Loth K, Billet A.   +8 more
europepmc   +1 more source

Impact of afucosylation strategy on antibody function: a comparative study of glycoengineered anti-CD20 antibodies Obinutuzumab and Obinutuzumab beta. [PDF]

MAbs
Shuang Q, Sun M, Lin G, Zhang L, Huang S, Shen Q, Jiang L, Yang L, Sun J, Chen H, Li F, Li J.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An Adenovirus Vaccine Potency Test

The Journal of Immunology, 1961
Summary Adenovirus vaccine potency estimates, based upon immune responses following multiple injections of fluid vaccine, were unreliable. As an alternative, a potency test based upon a single injection of vaccine with oil-adjuvant is described.
H, TINT, J, STONE
openaire   +2 more sources

Comparisons of outlier tests for potency bioassays

Pharmaceutical Statistics, 2019
SummaryPotency bioassays are used to measure biological activity. Consequently, potency is considered a critical quality attribute in manufacturing. Relative potency is measured by comparing the concentration‐response curves of a manufactured test batch with that of a reference standard. If the curve shapes are deemed similar, the test batch is said to
Perceval Sondag, Lingmin Zeng, Binbing Yu, Harry Yang, Steven Novick   +4 more
openaire   +2 more sources

Potency testing of acellular pertussis vaccines

Vaccine, 1992
The laboratory assessment of the potential of acellular pertussis vaccines to protect against human disease is a major problem. The mouse intracerebral challenge test, which is the accepted potency assay for whole cell pertussis vaccines, is not suitable for testing acellular vaccines, and more recently developed murine respiratory infection assays ...
A, Robinson, S G, Funnell
openaire   +2 more sources

Potency Testing of Live Measles Vaccine

Archives of Pediatrics & Adolescent Medicine, 1962
The preceding series of papers has furnished information pertaining to the number of infectious units of attenuated measles virus needed to immunize susceptible children. These presentations have also touched on the question of the optimum virus content of the live vaccine, both as it leaves the hands of the manufacturer and at the actual moment of ...
H M, MEYER, B E, BROOKS, R D, DOUGLAS, N G, ROGERS   +3 more
openaire   +2 more sources